29973-97-5

Basic information

• Product Name: 2-[3-(benzyloxy)phenyl]ethanamine hydrochloride (1:1)
• Synonyms: 2-[3-(benzyloxy)phenyl]ethan-1-amine hydrochloride
• CAS NO: 29973-97-5
• Molecular Formula: C₁₅H₁₇NO*ClH
• Molecular Weight: 263.7625
• Mol File: 29973-97-5.mol
• Article Data: 6

Chemical Properties

• Melting Point: 180 °C
• Boiling Point: 370.1°C at 760 mmHg
• Flash Point: 179.3°C
• Vapor Pressure: 1.13E-05mmHg at 25°C
• CAS DataBase Reference: 2-[3-(benzyloxy)phenyl]ethanamine hydrochloride (1:1)(CAS DataBase Reference)
• NIST Chemistry Reference: 2-[3-(benzyloxy)phenyl]ethanamine hydrochloride (1:1)(29973-97-5)
• EPA Substance Registry System: 2-[3-(benzyloxy)phenyl]ethanamine hydrochloride (1:1)(29973-97-5)

Safety Data

• Hazardous Substances Data: 29973-97-5(Hazardous Substances Data)

Usage

Organic compound

Consists of a benzyl group attached to an amine group

Form

Exists as a hydrochloride salt

Uses

Commonly used in medicinal chemistry and pharmaceutical research for the development of potential drugs and treatments

Applications

May have applications in organic synthesis and chemical reactions

Stability and solubility

The hydrochloride salt form allows for increased stability and solubility in aqueous solutions, making it easier to work with in laboratory settings

Versatility and importance

Considered a versatile and important chemical compound with various potential applications in the science and medical fields.

Upstream product

• 24550-32-1 1-(benzyloxy)-3-(2-nitrovinyl)benzene 
• 20967-96-8 2-(3-benzyloxyphenyl)acetonitrile 
• 588-05-6 m-tyramine 
• 129150-68-1 N-(t-butoxycarbonyl)-2-(3-hydroxyphenyl)-ethylamine 
• 132513-29-2 tert-butyl {2-[3-(benzyloxy)phenyl]ethyl}carbamate 
• 2039-67-0 2-(3-methoxyphenyl)-1-ethanamine 
• 38449-59-1 2-(3-hydroxyphenyl)ethylamine hydrobromide 

Downstream Products

• 29974-02-5 N-[2-(3-Benzyloxy-phenyl)-ethyl]-2-(3-bromo-4-methoxy-phenyl)-acetamide 
• 875305-11-6 [2-(3-benzyloxy-phenyl)-ethyl]-(4-tert-butyl-benzyl)-amine 
• 132513-29-2 tert-butyl {2-[3-(benzyloxy)phenyl]ethyl}carbamate 
• 637773-79-6 (E)-N-(3-benzyloxyphenethyl)-3-(pyridin-3-yl)-2-propenamide 
• 51061-22-4 2-(3-benzyloxyphenyl)ethylamine 
• 1233354-59-0 C₃₁H₃₁NO₇S 
• 1415684-09-1 (2S,3R,3aS,12bR)-1,2,3,3a,4,5,7,8-octahydro-10-benzyloxy-2-methyl-3-nitromethyl-5-oxo-cyclopenta[2,3]pyrrolo[2,1-a]isoquinoline 
• 1415684-10-4 (2S,3R,3aS,12bR)-1,2,3,3a,4,5,7,8-octahydro-10-benzyloxy-2-methyl-5-oxo-cyclopenta[2,3]pyrrolo[2,1-a]isoquinoline-3-carboxylic acid 
• 1415684-11-5 methyl ester (2S,3R,3aS,12bR)-1,2,3,3a,4,5,7,8-octahydro-10-benzyloxy-2-methyl-5-oxo-cyclopenta[2,3]pyrrolo[2,1-a]isoquinoline-3-carboxylic acid 
• 1443827-86-8 C₂₄H₂₃NO₃ 
• 1443827-79-9 N-(3-(benzyloxy)phenethyl)-2-(4-methoxyphenoxy)acetamide 
• 1443828-16-7 (6-(benzyloxy)-1-((4-methoxyphenoxy)methyl)-3,4-dihydroisoquinolin-2(1H)-yl)(phenyl)methanone 
• 1443828-17-8 (6-(benzyloxy)-1-((4-methoxyphenoxy)methyl)-3,4-dihydroisoquinolin-2(1H)-yl)(3-chlorophenyl)methanone 
• 1443828-18-9 (6-(benzyloxy)-1-((4-methoxyphenoxy)methyl)-3,4-dihydroisoquinolin-2(1H)-yl)(3-bromophenyl)methanone 

Relevant articles and documents

Synthesis and structure activity relationship of tetrahydroisoquinoline- based potentiators of GluN2C and GluN2D containing N-Methyl-D-aspartate receptors

We describe here the synthesis and evaluation of a series of tetrahydroisoquinolines that show subunit-selective potentiation of NMDA receptors containing the GluN2C or GluN2D subunits. Bischler-Napieralski conditions were employed in the key step for the

SYNTHESIS OF POLYCYCLIC ALKALOIDS

Disclosed embodiments concern polycyclic alkaloid compounds and methods for their use and synthesis. Particular embodiments concern polycyclic alkaloids having a fused, six-membered ring, while other embodiments concern polycyclic alkaloids having a fused

Heteroaryl and benzyl amide compounds

Compounds of formula I wherein R1, R2, R4, R5, A, B, D and n are as defined, and pharmaceutically acceptable salts thereof, processes for their preparation, their use as pharmaceuticals and pharmaceutical compositions comprising them.